Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  KHRNF | KHRWF | V.KHRN.WT.H

Healthcare Cannabis
Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line, the Company is focused on product sales in Latin America. The Company operates its own network of health centers (operating under the Zerenia brand) and Zerenia satellite clinics offering a suite of health, medical and surgical services, in alignment with both insurance company partners and private practice. Its subsidiaries include Khiron Life Sciences Corp. (Canada), Khiron Colombia S.A.S., Zerenia S.A.S., NettaGrowth International Inc., and others.


TSXV:KHRN.H - Post by User

Khiron Life Sciences Corp
Bullboard Posts
User Avatar Image
(162)
•••
Comment by Benedictuson Oct 02, 2019 1:52pm
222 Views
Post# 30188269

RE:RE:RE:All the sector is down ... just time to load .....

RE:RE:RE:All the sector is down ... just time to load ..... kyle, your .20 cent projection would value khrn at around a 22M market cap for a company projected to earn revs from 40 - 50M next year. So you believe khrn should sell for a forward psr of <.50 in one of the highest growth sectors in the market?!! I'm not buying it for a second.

I would agree their cash burn is steep as they aggressively pursue talent and continue their buildout and drag and drop strategy but overall this mgt is very competent and the timing of their last raise was excellent. So I just don't buy your logic. But if you have more compelling insights to add to justify your .20 price target, please share with the board. 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities